Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1980 2
1981 2
1982 1
1983 2
1984 2
1985 1
1987 1
1988 1
1995 1
1996 1
1997 2
1998 2
1999 1
2005 1
2006 3
2007 2
2008 4
2009 4
2010 1
2011 1
2019 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Hepatic disease and drug pharmacokinetics.
Williams RL, Mamelok RD. Williams RL, et al. Among authors: mamelok rd. Clin Pharmacokinet. 1980 Nov-Dec;5(6):528-47. doi: 10.2165/00003088-198005060-00002. Clin Pharmacokinet. 1980. PMID: 7002418 Review.
Therapeutic drug monitoring of mycophenolate mofetil in transplantation.
van Gelder T, Le Meur Y, Shaw LM, Oellerich M, DeNofrio D, Holt C, Holt DW, Kaplan B, Kuypers D, Meiser B, Toenshoff B, Mamelok RD. van Gelder T, et al. Among authors: mamelok rd. Ther Drug Monit. 2006 Apr;28(2):145-54. doi: 10.1097/01.ftd.0000199358.80013.bd. Ther Drug Monit. 2006. PMID: 16628123 Review.
Daclizumab to prevent rejection after cardiac transplantation.
Hershberger RE, Starling RC, Eisen HJ, Bergh CH, Kormos RL, Love RB, Van Bakel A, Gordon RD, Popat R, Cockey L, Mamelok RD. Hershberger RE, et al. Among authors: mamelok rd. N Engl J Med. 2005 Jun 30;352(26):2705-13. doi: 10.1056/NEJMoa032953. N Engl J Med. 2005. PMID: 15987919 Free article. Clinical Trial.
Time-dependent clearance of mycophenolic acid in renal transplant recipients.
van Hest RM, van Gelder T, Bouw R, Goggin T, Gordon R, Mamelok RD, Mathot RA. van Hest RM, et al. Among authors: mamelok rd. Br J Clin Pharmacol. 2007 Jun;63(6):741-52. doi: 10.1111/j.1365-2125.2006.02841.x. Epub 2007 Jan 3. Br J Clin Pharmacol. 2007. PMID: 17214827 Free PMC article.
Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study.
Neuberger JM, Mamelok RD, Neuhaus P, Pirenne J, Samuel D, Isoniemi H, Rostaing L, Rimola A, Marshall S, Mayer AD; ReSpECT Study Group. Neuberger JM, et al. Among authors: mamelok rd. Am J Transplant. 2009 Feb;9(2):327-36. doi: 10.1111/j.1600-6143.2008.02493.x. Epub 2008 Dec 15. Am J Transplant. 2009. PMID: 19120077 Free article. Clinical Trial.
Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial.
van Gelder T, Silva HT, de Fijter JW, Budde K, Kuypers D, Tyden G, Lohmus A, Sommerer C, Hartmann A, Le Meur Y, Oellerich M, Holt DW, Tönshoff B, Keown P, Campbell S, Mamelok RD. van Gelder T, et al. Among authors: mamelok rd. Transplantation. 2008 Oct 27;86(8):1043-51. doi: 10.1097/TP.0b013e318186f98a. Transplantation. 2008. PMID: 18946341 Clinical Trial.
37 results